New drug tested for Hard-to-Treat eczema
NCT ID NCT06094179
Summary
This study is testing an experimental drug called BAT6026 for adults with moderate to severe eczema that hasn't responded well to standard creams and ointments. Researchers are comparing different doses against a placebo to see which works best and is safest. The main goal is to see if the drug can reduce eczema severity by at least 75% after 16 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS ATOPIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jianzhong Zhang
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.